Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aeluma, Inc.N/A · Entity 6202 | Former Director and Officer | June 22, 2021 | June 24, 2021 |
| Amesite Inc.NONE · Entity 149985 | Director · President,Secretary,CEO & CFO | August 26, 2017 | May 01, 2018 |
| Augmedix, Inc.NONE · Entity 86996 | Former Director and Officer | October 05, 2020 | October 07, 2020 |
| Compass Therapeutics, Inc.NONE · Entity 5614 | Director · President, Sec, CEO, & CFO | July 29, 2018 | July 30, 2018 |
| DEEP FISSION, INC.NONE · Entity 5748 | Director · President, CEO, CFO, Secretary | August 26, 2025 | August 28, 2025 |
| Deep Isolation Nuclear, Inc.NONE · Entity 9903 | Director · President, CEO, CFO, Secretary | July 16, 2025 | July 18, 2025 |
| EXICURE, INC.NONE · Entity 8068 | Director · President, Secretary, CEO, CFO | September 22, 2017 | September 26, 2017 |
| Guerrilla RF, Inc.NONE · Entity 7285 | Director · President, CEO, CFO, Secretary | March 05, 2021 | July 14, 2021 |
| Margaree Acquisition Corp.NONE · Entity 29500 | Director · President, CEO, CFO, Secretary · 10% owner | July 17, 2026 | July 20, 2026 |
| Orielle Acquisition Corp.NONE · Entity 75992 | Director · President, CEO, CFO, Secretary | August 26, 2025 | August 28, 2025 |
| Primus Acquisition Inc.NONE · Entity 68795 | Director · President, CEO, CFO, Secretary | January 26, 2026 | January 27, 2026 |
| Range Acquisition Corp.NONE · Entity 72416 | Director · President, CEO, CFO, Secretary | December 01, 2025 | December 02, 2025 |
| Var Acquisition Corp.NONE · Entity 74862 | Director · President, CEO, CFO, Secretary | September 30, 2025 | September 30, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aeluma, Inc.
Report date June 22, 2021 · Filed June 24, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 200,000 |
Reported balance
After 2021-06-22 transaction · row 1
1 source rowRow 1 · 2021-06-22 · Other · Disposed 50,000 · Balance 200,000 F1: Pursuant to the terms of an Agreement and Plan of Merger and Reorganization, dated as of June 22, 2021, by and among the Issuer, Aeluma Operating Co. ("Acquisition Sub"), and Biond Photonics, Inc. (d.b.a. "Aeluma") ("Biond"), on June 22, 2021, Biond merged with and into Acquisition Sub, with Acquisition Sub continuing as the surviving entity (the "Merger") and as the Issuer's wholly-owned subsidiary. As a condition to the Merger, pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and canceled 50,000 shares of the Issuer's common stock prior to the consummation of the Merger. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of an Agreement and Plan of Merger and Reorganization, dated as of June 22, 2021, by and among the Issuer, Aeluma Operating Co. ("Acquisition Sub"), and Biond Photonics, Inc. (d.b.a. "Aeluma") ("Biond"), on June 22, 2021, Biond merged with and into Acquisition Sub, with Acquisition Sub continuing as the surviving entity (the "Merger") and as the Issuer's wholly-owned subsidiary. As a condition to the Merger, pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and canceled 50,000 shares of the Issuer's common stock prior to the consummation of the Merger. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger.
Amesite Inc.
Report date August 26, 2017 · Filed May 01, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 199,333 |
Reported balance
Holding disclosure · report date 2017-08-26 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 199,333 F1: Reflects the forward stock split of the Company's outstanding common stock at a ratio of 3.066668-for-1, effective as of March 27, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the forward stock split of the Company's outstanding common stock at a ratio of 3.066668-for-1, effective as of March 27, 2018.
Augmedix, Inc.
Report date October 05, 2020 · Filed October 07, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 160,000 |
Reported balance
After 2020-10-05 transaction · row 1
1 source rowRow 1 · 2020-10-05 · Other · Disposed 90,000 · Balance 160,000 F1: Pursuant to the terms of an Agreement and Plan of Merger and Reorganization, dated as of October 5, 2020, by and among the Issuer, August Acquisition Corp. ("Acquisition Sub"), and Augmedix Operating Company (f/k/a Augmedix, Inc.) ("Augmedix"), on October 5, 2020, Acquisition Sub merged with and into Augmedix, with Augmedix continuing as the surviving entity (the "Merger") and as the Issuer's wholly-owned subsidiary. As a condition to the Merger, pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and canceled 90,000 shares of the Issuer's common stock prior to the consummation of the Merger. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of an Agreement and Plan of Merger and Reorganization, dated as of October 5, 2020, by and among the Issuer, August Acquisition Corp. ("Acquisition Sub"), and Augmedix Operating Company (f/k/a Augmedix, Inc.) ("Augmedix"), on October 5, 2020, Acquisition Sub merged with and into Augmedix, with Augmedix continuing as the surviving entity (the "Merger") and as the Issuer's wholly-owned subsidiary. As a condition to the Merger, pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and canceled 90,000 shares of the Issuer's common stock prior to the consummation of the Merger. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger
Compass Therapeutics, Inc.
Report date July 29, 2018 · Filed July 30, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.0001SEC Table I · non-derivative | Direct | 250,000 |
Reported balance
Holding disclosure · report date 2018-07-29 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 250,000 |
DEEP FISSION, INC.
Report date August 26, 2025 · Filed August 28, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 275,000 |
Reported balance
After 2025-08-26 transaction · row 1
1 source rowRow 1 · 2025-08-26 · Purchase · Acquired 25,000 · Balance 275,000 |
Deep Isolation Nuclear, Inc.
Report date July 16, 2025 · Filed July 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 275,000 |
Reported balance
After 2025-07-16 transaction · row 1
1 source rowRow 1 · 2025-07-16 · Purchase · Acquired 25,000 · Balance 275,000 |
EXICURE, INC.
Report date September 22, 2017 · Filed September 26, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 103,160 |
Reported balance
After 2017-09-22 transaction · row 1
1 source rowRow 1 · 2017-09-22 · Grant · Acquired 38,160 · Balance 103,160 F1: These shares were received for services rendered in connection with a proposed merger among the issuer, Exicure, Inc., and Max-1 Acquisition Sub, Inc., a wholly owned subsidiary of the issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were received for services rendered in connection with a proposed merger among the issuer, Exicure, Inc., and Max-1 Acquisition Sub, Inc., a wholly owned subsidiary of the issuer.
Guerrilla RF, Inc.
Report date March 05, 2021 · Filed July 14, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 250,000 |
Reported balance
Holding disclosure · report date 2021-03-05 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 250,000 |
Margaree Acquisition Corp.
Report date July 17, 2026 · Filed July 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,500,000 |
Reported balance
Holding disclosure · report date 2026-07-17 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 2,500,000 |
Orielle Acquisition Corp.
Report date August 26, 2025 · Filed August 28, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 325,000 |
Reported balance
After 2025-08-26 transaction · row 1
1 source rowRow 1 · 2025-08-26 · Purchase · Acquired 50,000 · Balance 325,000 |
Primus Acquisition Inc.
Report date January 26, 2026 · Filed January 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,500,000 |
Reported balance
Holding disclosure · report date 2026-01-26 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 2,500,000 |
Range Acquisition Corp.
Report date December 01, 2025 · Filed December 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,500,000 |
Reported balance
Holding disclosure · report date 2025-12-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 2,500,000 |
Var Acquisition Corp.
Report date September 30, 2025 · Filed September 30, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,500,000 |
Reported balance
Holding disclosure · report date 2025-09-30 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 2,500,000 |
Past disclosures · reporting ended (5)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Lomond Therapeutics Holdings, Inc.
Report date November 01, 2024 · Filed November 05, 2024
Section 16 reporting ended · disclosed 2024-11-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 175,000 |
Reported balance
After 2024-11-01 transaction · row 1
1 source rowRow 1 · 2024-11-01 · Other · Disposed 75,000 · Balance 175,000 F1: As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated as of November 1, 2024, and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled for no consideration 75,000 shares of Issuer's common stock prior to the consummation of the Merger on November 1, 2024. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger. |
Filing footnotes · ownership attribution and instrument terms
F1: As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated as of November 1, 2024, and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled for no consideration 75,000 shares of Issuer's common stock prior to the consummation of the Merger on November 1, 2024. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger.
Matternet, Inc.
Report date May 22, 2026 · Filed May 28, 2026
Section 16 reporting ended · disclosed 2026-05-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 325,000 |
Reported balance
After 2026-05-22 transaction · row 1
1 source rowRow 1 · 2026-05-22 · Other · Disposed 2,175,000 · Balance 325,000 F1: As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated May 22, 2026 (the merger contemplated under such agreement, "Merger"), and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled, for no consideration, 2,175,000 shares of the Issuer's common stock prior to the consummation of the Merger on May 22, 2026 ("Closing Date"). The reporting person resigned as the President, Chief Executive Officer, Chief Financial Officer, Director, and Secretary of the Issuer upon consummation of the Merger. |
Filing footnotes · ownership attribution and instrument terms
F1: As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated May 22, 2026 (the merger contemplated under such agreement, "Merger"), and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled, for no consideration, 2,175,000 shares of the Issuer's common stock prior to the consummation of the Merger on May 22, 2026 ("Closing Date"). The reporting person resigned as the President, Chief Executive Officer, Chief Financial Officer, Director, and Secretary of the Issuer upon consummation of the Merger.
Serve Robotics Inc. /DE/
Report date July 31, 2023 · Filed August 03, 2023
Section 16 reporting ended · disclosed 2023-08-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 125,000 |
Reported balance
After 2023-07-31 transaction · row 1
1 source rowRow 1 · 2023-07-31 · Other · Disposed 125,000 · Balance 125,000 F1: As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated as of July 31, 2023, and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled for no consideration 125,000 shares of Issuer's common stock prior to the consummation of the merger. The reporting person resigned as an officer and director of the Issuer upon consummation of the merger. |
Filing footnotes · ownership attribution and instrument terms
F1: As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated as of July 31, 2023, and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled for no consideration 125,000 shares of Issuer's common stock prior to the consummation of the merger. The reporting person resigned as an officer and director of the Issuer upon consummation of the merger.
SmartKem, Inc.
Report date February 23, 2021 · Filed February 26, 2021
Section 16 reporting ended · disclosed 2021-02-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.0001SEC Table I · non-derivative | Direct | 200,000 |
Reported balance
After 2021-02-23 transaction · row 1
1 source rowRow 1 · 2021-02-23 · Other · Disposed 50,000 · Balance 200,000 F1: Pursuant to the terms of a Share Exchange Agreement, dated as of February 23, 2021, by and among the Issuer, SmartKem Inc. (f/k/a SmartKem Limited) ("SmartKem"), and the former shareholders of SmartKem, on February 23, 2021, all of the equity interests in SmartKem, except certain "deferred shares," exchanged for shares of Issuer's common stock, with SmartKem continuing as the Issuer's wholly owned subsidiary (the "Exchange"). As a condition to the Exchange, pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and canceled 50,000 shares of the Issuer's common stock prior to the consummation of the Exchange. The reporting person resigned as a director and officer of the Issuer upon consummation of the Exchange. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of a Share Exchange Agreement, dated as of February 23, 2021, by and among the Issuer, SmartKem Inc. (f/k/a SmartKem Limited) ("SmartKem"), and the former shareholders of SmartKem, on February 23, 2021, all of the equity interests in SmartKem, except certain "deferred shares," exchanged for shares of Issuer's common stock, with SmartKem continuing as the Issuer's wholly owned subsidiary (the "Exchange"). As a condition to the Exchange, pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and canceled 50,000 shares of the Issuer's common stock prior to the consummation of the Exchange. The reporting person resigned as a director and officer of the Issuer upon consummation of the Exchange.
Transphorm, Inc.
Report date February 12, 2020 · Filed February 14, 2020
Section 16 reporting ended · disclosed 2020-02-14. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.0001SEC Table I · non-derivative | Direct | 125,000 |
Reported balance
After 2020-02-12 transaction · row 1
1 source rowRow 1 · 2020-02-12 · Other · Disposed 25,000 · Balance 125,000 F1: Pursuant to the terms and conditions of that certain Agreement and Plan of Merger and Reorganization, dated as of February 12, 2020, by and among Transphorm, Inc., f/k/a Peninsula Acquisition Corporation (the "Issuer"), Peninsula Acquisition Sub, Inc. ("Acquisition Sub"), and Transphorm Technology, Inc., f/k/a Transphorm, Inc. ("Transphorm"), on February 12, 2020, Acquisition Sub merged with and into Transphorm, with Transphorm continuing as the surviving entity (the "Merger") and as the Issuer's wholly-owned subsidiary. Pursuant to the terms of a stock forfeiture letter, the reporting person forfeited and canceled 25,000 shares of the Issuer's common stock immediately prior to the consummation of the Merger. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms and conditions of that certain Agreement and Plan of Merger and Reorganization, dated as of February 12, 2020, by and among Transphorm, Inc., f/k/a Peninsula Acquisition Corporation (the "Issuer"), Peninsula Acquisition Sub, Inc. ("Acquisition Sub"), and Transphorm Technology, Inc., f/k/a Transphorm, Inc. ("Transphorm"), on February 12, 2020, Acquisition Sub merged with and into Transphorm, with Transphorm continuing as the surviving entity (the "Merger") and as the Issuer's wholly-owned subsidiary. Pursuant to the terms of a stock forfeiture letter, the reporting person forfeited and canceled 25,000 shares of the Issuer's common stock immediately prior to the consummation of the Merger.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 22, 2026 Filed May 28, 2026 00:46 UTC | Matternet, Inc. NONE · Entity 26314 | OtherCommon Stock | 2,175,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-061677 · ownership.xml · nonDerivative · entry 1 Jacobs Ian Seth · CIK 0001707297 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 325,000 F1 · kind: As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated May 22, 2026 (the merger contemplated under such agreement, "Merger"), and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled, for no consideration, 2,175,000 shares of the Issuer's common stock prior to the consummation of the Merger on May 22, 2026 ("Closing Date"). The reporting person resigned as the President, Chief Executive Officer, Chief Financial Officer, Director, and Secretary of the Issuer upon consummation of the Merger. F1 · price: As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated May 22, 2026 (the merger contemplated under such agreement, "Merger"), and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled, for no consideration, 2,175,000 shares of the Issuer's common stock prior to the consummation of the Merger on May 22, 2026 ("Closing Date"). The reporting person resigned as the President, Chief Executive Officer, Chief Financial Officer, Director, and Secretary of the Issuer upon consummation of the Merger. Read SEC document |
| August 26, 2025 Filed Aug 28, 2025 23:00 UTC | DEEP FISSION, INC. NONE · Entity 5748 | PurchaseCommon Stock | 25,000 | $0.00 | $2.50 |
DisclosureSEC source: 0001213900-25-081956 · ownership.xml · nonDerivative · entry 1 Jacobs Ian Seth · CIK 0001707297 · Director · President, CEO, CFO, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 275,000 Read SEC document |
| August 26, 2025 Filed Aug 28, 2025 23:02 UTC | Orielle Acquisition Corp. NONE · Entity 75992 | PurchaseCommon Stock | 50,000 | $0.00 | $5.00 |
DisclosureSEC source: 0001213900-25-081958 · ownership.xml · nonDerivative · entry 1 Jacobs Ian Seth · CIK 0001707297 · Director · President, CEO, CFO, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 325,000 Read SEC document |
| July 16, 2025 Filed Jul 18, 2025 22:08 UTC | Deep Isolation Nuclear, Inc. NONE · Entity 9903 | PurchaseCommon Stock | 25,000 | $0.00 | $2.50 |
DisclosureSEC source: 0001213900-25-065807 · ownership.xml · nonDerivative · entry 1 Jacobs Ian Seth · CIK 0001707297 · Director · President, CEO, CFO, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 275,000 Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 23:33 UTC | Lomond Therapeutics Holdings, Inc. NONE · Entity 86303 | OtherCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-094680 · ownership.xml · nonDerivative · entry 1 Jacobs Ian Seth · CIK 0001707297 · Former Director and officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 F1 · kind: As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated as of November 1, 2024, and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled for no consideration 75,000 shares of Issuer's common stock prior to the consummation of the Merger on November 1, 2024. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger. F1 · price: As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated as of November 1, 2024, and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled for no consideration 75,000 shares of Issuer's common stock prior to the consummation of the Merger on November 1, 2024. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger. Read SEC document |
| July 31, 2023 Filed Aug 3, 2023 01:49 UTC | Serve Robotics Inc. /DE/ NONE · Entity 5633 | OtherCommon Stock | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-23-062753 · ownership.xml · nonDerivative · entry 1 Jacobs Ian Seth · CIK 0001707297 · Former Director and Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 F1 · kind: As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated as of July 31, 2023, and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled for no consideration 125,000 shares of Issuer's common stock prior to the consummation of the merger. The reporting person resigned as an officer and director of the Issuer upon consummation of the merger. F1 · price: As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated as of July 31, 2023, and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled for no consideration 125,000 shares of Issuer's common stock prior to the consummation of the merger. The reporting person resigned as an officer and director of the Issuer upon consummation of the merger. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 01:51 UTC | Aeluma, Inc. N/A · Entity 6202 | OtherCommon stock, par value $0.0001 per share | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-033882 · ownership.xml · nonDerivative · entry 1 Jacobs Ian Seth · CIK 0001707297 · Former Director and Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 F1 · kind: Pursuant to the terms of an Agreement and Plan of Merger and Reorganization, dated as of June 22, 2021, by and among the Issuer, Aeluma Operating Co. ("Acquisition Sub"), and Biond Photonics, Inc. (d.b.a. "Aeluma") ("Biond"), on June 22, 2021, Biond merged with and into Acquisition Sub, with Acquisition Sub continuing as the surviving entity (the "Merger") and as the Issuer's wholly-owned subsidiary. As a condition to the Merger, pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and canceled 50,000 shares of the Issuer's common stock prior to the consummation of the Merger. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger. F1 · price: Pursuant to the terms of an Agreement and Plan of Merger and Reorganization, dated as of June 22, 2021, by and among the Issuer, Aeluma Operating Co. ("Acquisition Sub"), and Biond Photonics, Inc. (d.b.a. "Aeluma") ("Biond"), on June 22, 2021, Biond merged with and into Acquisition Sub, with Acquisition Sub continuing as the surviving entity (the "Merger") and as the Issuer's wholly-owned subsidiary. As a condition to the Merger, pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and canceled 50,000 shares of the Issuer's common stock prior to the consummation of the Merger. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger. Read SEC document |
| February 23, 2021 Filed Feb 26, 2021 02:44 UTC | SmartKem, Inc. NONE · Entity 8554 | OtherCommon Stock, par value $0.0001 | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-028484 · tm217635-1_4seq1.xml · nonDerivative · entry 1 Jacobs Ian Seth · CIK 0001707297 · Former Officer and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 F1 · kind: Pursuant to the terms of a Share Exchange Agreement, dated as of February 23, 2021, by and among the Issuer, SmartKem Inc. (f/k/a SmartKem Limited) ("SmartKem"), and the former shareholders of SmartKem, on February 23, 2021, all of the equity interests in SmartKem, except certain "deferred shares," exchanged for shares of Issuer's common stock, with SmartKem continuing as the Issuer's wholly owned subsidiary (the "Exchange"). As a condition to the Exchange, pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and canceled 50,000 shares of the Issuer's common stock prior to the consummation of the Exchange. The reporting person resigned as a director and officer of the Issuer upon consummation of the Exchange. F1 · price: Pursuant to the terms of a Share Exchange Agreement, dated as of February 23, 2021, by and among the Issuer, SmartKem Inc. (f/k/a SmartKem Limited) ("SmartKem"), and the former shareholders of SmartKem, on February 23, 2021, all of the equity interests in SmartKem, except certain "deferred shares," exchanged for shares of Issuer's common stock, with SmartKem continuing as the Issuer's wholly owned subsidiary (the "Exchange"). As a condition to the Exchange, pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and canceled 50,000 shares of the Issuer's common stock prior to the consummation of the Exchange. The reporting person resigned as a director and officer of the Issuer upon consummation of the Exchange. Read SEC document |
| October 05, 2020 Filed Oct 7, 2020 21:56 UTC | Augmedix, Inc. NONE · Entity 86996 | OtherCommon stock, par value $0.0001 per share | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-030539 · ownership.xml · nonDerivative · entry 1 Jacobs Ian Seth · CIK 0001707297 · Former Director and Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 F1 · kind: Pursuant to the terms of an Agreement and Plan of Merger and Reorganization, dated as of October 5, 2020, by and among the Issuer, August Acquisition Corp. ("Acquisition Sub"), and Augmedix Operating Company (f/k/a Augmedix, Inc.) ("Augmedix"), on October 5, 2020, Acquisition Sub merged with and into Augmedix, with Augmedix continuing as the surviving entity (the "Merger") and as the Issuer's wholly-owned subsidiary. As a condition to the Merger, pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and canceled 90,000 shares of the Issuer's common stock prior to the consummation of the Merger. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger F1 · price: Pursuant to the terms of an Agreement and Plan of Merger and Reorganization, dated as of October 5, 2020, by and among the Issuer, August Acquisition Corp. ("Acquisition Sub"), and Augmedix Operating Company (f/k/a Augmedix, Inc.) ("Augmedix"), on October 5, 2020, Acquisition Sub merged with and into Augmedix, with Augmedix continuing as the surviving entity (the "Merger") and as the Issuer's wholly-owned subsidiary. As a condition to the Merger, pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and canceled 90,000 shares of the Issuer's common stock prior to the consummation of the Merger. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 19:30 UTC | Transphorm, Inc. NONE · Entity 15192 | OtherCommon Stock, par value $0.0001 | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-004042 · ownership.xml · nonDerivative · entry 1 Jacobs Ian Seth · CIK 0001707297 · Former Officer and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 F1 · kind: Pursuant to the terms and conditions of that certain Agreement and Plan of Merger and Reorganization, dated as of February 12, 2020, by and among Transphorm, Inc., f/k/a Peninsula Acquisition Corporation (the "Issuer"), Peninsula Acquisition Sub, Inc. ("Acquisition Sub"), and Transphorm Technology, Inc., f/k/a Transphorm, Inc. ("Transphorm"), on February 12, 2020, Acquisition Sub merged with and into Transphorm, with Transphorm continuing as the surviving entity (the "Merger") and as the Issuer's wholly-owned subsidiary. Pursuant to the terms of a stock forfeiture letter, the reporting person forfeited and canceled 25,000 shares of the Issuer's common stock immediately prior to the consummation of the Merger. F1 · price: Pursuant to the terms and conditions of that certain Agreement and Plan of Merger and Reorganization, dated as of February 12, 2020, by and among Transphorm, Inc., f/k/a Peninsula Acquisition Corporation (the "Issuer"), Peninsula Acquisition Sub, Inc. ("Acquisition Sub"), and Transphorm Technology, Inc., f/k/a Transphorm, Inc. ("Transphorm"), on February 12, 2020, Acquisition Sub merged with and into Transphorm, with Transphorm continuing as the surviving entity (the "Merger") and as the Issuer's wholly-owned subsidiary. Pursuant to the terms of a stock forfeiture letter, the reporting person forfeited and canceled 25,000 shares of the Issuer's common stock immediately prior to the consummation of the Merger. Read SEC document |
| September 22, 2017 Filed Sep 26, 2017 22:05 UTC | EXICURE, INC. NONE · Entity 8068 | GrantCommon Stock | 38,160 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-17-010015 · f4092217jacobs_max1acq.xml · nonDerivative · entry 1 Jacobs Ian Seth · CIK 0001707297 · Director · President, Secretary, CEO, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,160 F1 · price: These shares were received for services rendered in connection with a proposed merger among the issuer, Exicure, Inc., and Max-1 Acquisition Sub, Inc., a wholly owned subsidiary of the issuer. Read SEC document |
| June 15, 2017 Filed Jun 19, 2017 23:40 UTC | EXICURE, INC. NONE · Entity 8068 | SaleCommon Stock | 35,000 | $0.03 | $875.00 |
DisclosureSEC source: 0001213900-17-006618 · f4061517jacobs_max1acq.xml · nonDerivative · entry 1 Jacobs Ian Seth · CIK 0001707297 · Director · President, Secretary, CEO, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 F1 · shares: The disposed shares were originally acquired from the Issuer in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.